EverSource Wealth Advisors’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.89K Sell
60
-411
-87% -$28.9K ﹤0.01% 3286
2026
Q1
$26.9K Buy
471
+20
+4% +$1.16K ﹤0.01% 2316
2025
Q4
$22.8K Buy
451
+191
+73% +$9.77K ﹤0.01% 2297
2025
Q3
$13K Buy
260
+4
+2% +$183 ﹤0.01% 2671
2025
Q2
$10.3K Buy
256
+222
+653% +$8.27K ﹤0.01% 2787
2025
Q1
$1.19K Buy
34
+22
+183% +$867 ﹤0.01% 3164
2024
Q4
$469 Buy
+12
New +$431 ﹤0.01% 3221
2024
Q1
Sell
-50
Closed -$1.95K 2967
2023
Q4
$1.95K Buy
+50
New +$1.62K ﹤0.01% 2175
2022
Q4
Sell
-86
Closed -$3K 2403
2022
Q3
$3K Sell
86
-52
-38% -$2.25K ﹤0.01% 1570
2022
Q2
$7K Sell
138
-288
-68% -$13.4K ﹤0.01% 1159
2022
Q1
$23K Sell
426
-29
-6% -$1.53K 0.01% 648
2021
Q4
$23K Buy
+455
New +$26.8K 0.01% 630

Other funds holding PRLB

EverSource Wealth Advisors's PRLB Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Protolabs (PRLB) stake by 87% in Q2 2026, selling an estimated $28.9K and leaving 60 shares worth $4.89K. The position accounts for ﹤0.01% of the portfolio, ranked #3286.

EverSource Wealth Advisors first reported a position in PRLB in Q4 2021 and has held it in 12 quarters since. The position peaked at $26.9K in Q1 2026. 277 funds tracked by Wall St. Rank hold PRLB as of Q2 2026.

  • EverSource Wealth Advisors held 60 shares of Protolabs worth $4.89K as of Q2 2026.
  • EverSource Wealth Advisors sold 411 Protolabs shares in Q2 2026, an estimated $28.9K.
  • Protolabs made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3286 holding.
  • EverSource Wealth Advisors first reported a position in Protolabs in Q4 2021 and has held it in 12 quarters since.
  • EverSource Wealth Advisors's Protolabs position peaked at $26.9K in Q1 2026.
  • 277 funds tracked by Wall St. Rank held Protolabs as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.